KLRD1 and neoplasm: Thus, more basic research into the molecular basis and cell biology of activating NK cell receptor signalling in response to soluble tumour ligands, such as PDGF-DD and MULT1, is required and will inform methods to enhance NK cell targeting to tumours and stimulate their functions in vivo.